Literature DB >> 9417815

Nociceptive responses in interleukin-6-deficient mice to peripheral inflammation and peripheral nerve section.

X J Xu1, J X Hao, S Andell-Jonsson, V Poli, T Bartfai, Z Wiesenfeld-Hallin.   

Abstract

The cutaneous nociceptive response threshold to mechanical and thermal stimulation, the development of hyperalgesia and plasma extravasation after subcutaneous injection of carrageenan and the development of autotomy behaviour after nerve section were assessed in interleukin-6-deficient (IL-6-/-) and age-matched wild-type (IL-6+/+) mice. IL-6-/- mice had significantly lower response threshold to both mechanical and thermal stimulation in comparison to IL-6+/+ controls. Both IL-6-/- and IL-6+/+ mice developed hyperalgesia to mechanical and thermal stimulation after localized carrageenan injection, but the magnitude of the hyperalgesia was less in the IL-6-/- than in the IL-6+/+ controls. IL-6-/- mice also exhibited less plasma extravasation after carrageenan injection. No difference was noted between males and females in basal nociception and inflammatory hyperalgesia. However, female IL-6-/- mice exhibited autotomy behaviour, a sign of neuropathic pain, significantly more frequently and after a shorter interval following peripheral nerve injury than male IL-6-/- or male and female IL-6+/+ mice. It is suggested that IL-6-/- mice exhibited numerous changes in nociceptive responses compared to controls, some of which are sex related. The mechanisms of these changes in relation to null-mutation of the IL-6 gene and the influence of genetic background are discussed. 1997 Academic Press Limited.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9417815     DOI: 10.1006/cyto.1997.0243

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  27 in total

1.  Dose-dependent induction of IL-6 by plant-derived proteases in vitro.

Authors:  B Rose; C Herder; H Löffler; G Meierhoff; N C Schloot; M Walz; S Martin
Journal:  Clin Exp Immunol       Date:  2006-01       Impact factor: 4.330

2.  Local effects of recombinant rat interleukin-6 on the peripheral nervous system.

Authors:  G Deretzi; S H Pelidou; L P Zou; C Quiding; J Zhu
Journal:  Immunology       Date:  1999-08       Impact factor: 7.397

Review 3.  IL-4, JAK-STAT signaling, and pain.

Authors:  Melanie Busch-Dienstfertig; Sara González-Rodríguez
Journal:  JAKSTAT       Date:  2014-01-02

4.  The Red Nucleus Interleukin-6 Participates in the Maintenance of Neuropathic Pain Induced by Spared Nerve Injury.

Authors:  Cui-Ping Ding; Yu-Shun Xue; Jing Yu; Yi-Jie Guo; Xiao-Yan Zeng; Jun-Yang Wang
Journal:  Neurochem Res       Date:  2016-08-03       Impact factor: 3.996

Review 5.  Role of interleukins, IGF and stem cells in BPH.

Authors:  Ian D McLaren; Travis J Jerde; Wade Bushman
Journal:  Differentiation       Date:  2011-08-23       Impact factor: 3.880

6.  IL-6 induced upregulation of T-type Ca2+ currents and sensitization of DRG nociceptors is attenuated by MNK inhibition.

Authors:  Vivek Jeevakumar; Aysha Khalid Al Sardar; Farah Mohamed; Clay Matthew Smithhart; Theodore Price; Gregory Dussor
Journal:  J Neurophysiol       Date:  2020-06-10       Impact factor: 2.714

7.  Sensory impairments and delayed regeneration of sensory axons in interleukin-6-deficient mice.

Authors:  J Zhong; I D Dietzel; P Wahle; M Kopf; R Heumann
Journal:  J Neurosci       Date:  1999-06-01       Impact factor: 6.167

8.  Spinal activity of interleukin 6 mediates myelin basic protein-induced allodynia.

Authors:  Justin S Ko; Kelly A Eddinger; Mila Angert; Andrei V Chernov; Jennifer Dolkas; Alex Y Strongin; Tony L Yaksh; Veronica I Shubayev
Journal:  Brain Behav Immun       Date:  2016-03-09       Impact factor: 7.217

9.  Treatment of neuroinflammation by soluble tumor necrosis factor receptor Type II fused to a thermally responsive carrier.

Authors:  Mohammed F Shamji; Liufang Jing; Jun Chen; Priscilla Hwang; Odelia Ghodsizadeh; Allan H Friedman; William J Richardson; Lori A Setton
Journal:  J Neurosurg Spine       Date:  2008-08

10.  Novel treatment of neuroinflammation against low back pain by soluble fullerol nanoparticles.

Authors:  Qihai Liu; Li Jin; Brian H Mahon; Mahendra D Chordia; Francis H Shen; Xudong Li
Journal:  Spine (Phila Pa 1976)       Date:  2013-08-01       Impact factor: 3.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.